Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
de Kraker AT, Kenemans P, Smolders RG, Kroeks MV, van der Mooren MJ. de Kraker AT, et al. Among authors: van der mooren mj. Eur J Obstet Gynecol Reprod Biol. 2009 Feb;142(2):139-44. doi: 10.1016/j.ejogrb.2008.10.007. Epub 2008 Dec 17. Eur J Obstet Gynecol Reprod Biol. 2009. PMID: 19095343 Clinical Trial.
The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: a randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women.
Vogelvang TE, Mijatovic V, Kenemans P, Emeis JJ, Heijst JA, van der Mooren MJ. Vogelvang TE, et al. Among authors: van der mooren mj. Am J Obstet Gynecol. 2005 Oct;193(4):1384-94. doi: 10.1016/j.ajog.2005.02.083. Am J Obstet Gynecol. 2005. PMID: 16202731 Clinical Trial.
Treatment of dysfunctional uterine bleeding in the perimenopause: the effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment--a randomized, placebo-controlled, double-blind trial.
Franke HR, Snaaijer FF, Houben PW, van der Mooren MJ. Franke HR, et al. Among authors: van der mooren mj. Gynecol Endocrinol. 2006 Dec;22(12):692-7. doi: 10.1080/09513590601015101. Gynecol Endocrinol. 2006. PMID: 17162712 Clinical Trial.
106 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page